PMID- 23622731
OWN - NLM
STAT- MEDLINE
DCOM- 20140320
LR  - 20220408
IS  - 1872-7654 (Electronic)
IS  - 0301-2115 (Linking)
VI  - 169
IP  - 2
DP  - 2013 Jul
TI  - Primary fallopian tube carcinoma.
PG  - 155-61
LID - S0301-2115(13)00168-1 [pii]
LID - 10.1016/j.ejogrb.2013.03.023 [doi]
AB  - Primary fallopian tube carcinoma (PFTC) is a rare gynaecological tumour that 
      accounts for 0.14-1.8% of genital malignancies. The most common age of occurrence 
      is between 40 and 65 years, and the mean age is 55 years. The factors that 
      contribute to its appearance are not well known. Population studies show that the 
      mean incidence of PFTC is 3.6 per million women per annum. Overall survival 
      percentages for patients with PFTC are generally low, in the range of 22-57%. 
      Pre-operative diagnosis is rare and PFTC is usually confirmed by a pathologist, 
      but earlier diagnosis with early clinical manifestation and prompt investigation 
      improves the prognosis. Both PFTC and epithelial ovarian cancer (EOC) are treated 
      with similar surgical and chemotherapy methods. Studies have shown that the 
      prognosis for PFTC is worse than that for EOC or other primary gynaecological 
      tumours. This article reviews and presents the current updates of this rare 
      gynaecological malignancy.
CI  - Copyright (c) 2013 Elsevier Ireland Ltd. All rights reserved.
FAU - Kalampokas, E
AU  - Kalampokas E
AD  - University of Athens Medical School, Second Department of Obstetrics and 
      Gynaecology, Aretaieio Hospital, Athens, Greece. kalamp@yahoo.com
FAU - Kalampokas, T
AU  - Kalampokas T
FAU - Tourountous, I
AU  - Tourountous I
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20130423
PL  - Ireland
TA  - Eur J Obstet Gynecol Reprod Biol
JT  - European journal of obstetrics, gynecology, and reproductive biology
JID - 0375672
SB  - IM
MH  - Carcinoma/*diagnosis/epidemiology/therapy
MH  - Fallopian Tube Neoplasms/*diagnosis/epidemiology/therapy
MH  - Female
MH  - Humans
MH  - Incidence
MH  - Neoplasm Staging
MH  - Prognosis
MH  - Risk Factors
MH  - Socioeconomic Factors
OTO - NOTNLM
OT  - Fallopian tube carcinoma
OT  - High-grade serous carcinoma
OT  - Incidence
OT  - Risk factors
OT  - Treatment
EDAT- 2013/04/30 06:00
MHDA- 2014/03/22 06:00
CRDT- 2013/04/30 06:00
PHST- 2012/07/19 00:00 [received]
PHST- 2013/03/07 00:00 [revised]
PHST- 2013/03/09 00:00 [accepted]
PHST- 2013/04/30 06:00 [entrez]
PHST- 2013/04/30 06:00 [pubmed]
PHST- 2014/03/22 06:00 [medline]
AID - S0301-2115(13)00168-1 [pii]
AID - 10.1016/j.ejogrb.2013.03.023 [doi]
PST - ppublish
SO  - Eur J Obstet Gynecol Reprod Biol. 2013 Jul;169(2):155-61. doi: 
      10.1016/j.ejogrb.2013.03.023. Epub 2013 Apr 23.